Skip to content
10-K

Annual Report

BIOCLINICA INC

0001104659-12-013167

← back to feed
Filed
Feb 27, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Jan 31, 2012 15.65M sh
Current Liabilities FY 2011 · Dec 31, 2010 $19.83M
Total Liabilities FY 2011 · Dec 31, 2010 $25.15M
Current Assets FY 2011 · Dec 31, 2010 $28.44M
Total Assets FY 2011 · Dec 31, 2010 $80.03M
Shares Diluted FY 2011 · Dec 31, 2009 15.1M sh
Capex FY 2011 · Dec 31, 2009 $2.76M
Operating Cash Flow FY 2011 · Dec 31, 2009 $7.55M
Eps Diluted FY 2011 · Dec 31, 2009 $0.20
Eps Basic FY 2011 · Dec 31, 2009 $0.21
Sga Expense FY 2011 · Dec 31, 2009 $7.41M
Net Income FY 2011 · Dec 31, 2009 $2.96M
Operating Income FY 2011 · Dec 31, 2009 $4.69M
Revenue FY 2011 · Dec 31, 2009 $72.72M
Cash And Equivalents FY 2011 · Dec 31, 2008 $14.27M
Stockholders Equity FY 2011 · Dec 31, 2008 $43.41M